Fund Details
Cencora Ventures
Overview
Encouraging entrepreneurial firms for healthier futures globally.
Founded
2022
Deals · 12mo
2
Links
Stage focus
Series A
Series B
Geographic focus
United States
Sector focus
—
Investment portfolio
6rounds
| NAME | DATE | SIZE | |
|---|---|---|---|
NexCure | Mar 2026Participated | $19 MSeries A | |
Risa Labs | Jan 2026Led | $11 MSeries A | |
Lumata Health | Mar 2025Led | $23 MSeries B | |
Atropos Health | May 2024Participated | $33 MSeries B | |
Acclinate | May 2024Led | $7 MSeries A | |
Sempre Health | Sep 2023Participated | $20 MOther Equity | |
NexCure | Mar 2026Participated | $19 MSeries A | |
Risa Labs | Jan 2026Led | $11 MSeries A | |
Lumata Health | Mar 2025Led | $23 MSeries B | |
Atropos Health | May 2024Participated | $33 MSeries B | |
Acclinate | May 2024Led | $7 MSeries A | |
Sempre Health | Sep 2023Participated | $20 MOther Equity |
6 Items
6
Items
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series A | 2 | 1 |
| Series B | 1 | 1 |
| Other Equity | 0 | 1 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Sep '23 | 1 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 2 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 1 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 1 |
| Feb '26 | 0 |
| Mar '26 | 1 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 5 |
| Enterprise Software | 1 |
| AI & Machine Learning | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 1 |
| $10M-$25M | 4 |
| $25M-$50M | 1 |
| $50M-$100M | 0 |
| $100M-$250M | 0 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 1 of 1 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 6 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| McKesson Ventures | 2 |
| Oncology Ventures | 2 |
| BlueCross BlueShield Venture Partners | 1 |
| Breyer Capital | 1 |
| Cortado Ventures | 1 |
| Echo Health Ventures | 1 |
| Emerson Collective | 1 |
| Industry Ventures | 1 |
| Labcorp | 1 |
| Latimer Ventures | 1 |
| LRVHealth | 1 |
| Merck | 1 |
| Optum Ventures | 1 |
| Presidio Ventures | 1 |
| RA Capital Management | 1 |
| UPMC Enterprises | 1 |
| Valtruis | 1 |
| Z21 Ventures | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 3 | 50% |
| Participating | 3 | 50% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 1 | 33% |
| Co-led | 2 | 67% |